SSE Exchange | CN Country |
Jinling Pharmaceutical Company Limited is a prominent name in the Chinese pharmaceutical industry, known for its significant contribution in manufacturing and selling pharmaceutical products and medical devices. Founded in 1998 and having its headquarters in Nanjing, China, the company has established itself as a crucial provider of medical solutions within the country. With a focus on addressing various health issues through its comprehensive range of products, Jinling Pharmaceutical has earned a reputation for its innovation, quality, and the ability to cater to specific medical needs. The company's commitment to providing effective healthcare solutions is evident through its diverse portfolio, which includes treatments for thrombosis and sequelae, iron deficiency anemia, malignant tumors, and offering effective solutions for wound hemostasis among other medical conditions.
Designed for the treatment of various vascular disorders, including thromboangiitis obliterans, arteriosclerosis obliterans, and cerebral thrombosis, among others. These solutions are indicative of Jinling’s expertise in addressing complex vascular health issues through advanced pharmaceutical formulations.
Aimed at preventing and treating iron deficiency anemia, these tablets demonstrate Jinling Pharmaceutical’s commitment to combating prevalent health conditions with effective and accessible solutions.
This product stands out for its application in the treatment of malignant tumors, showcasing Jinling Pharmaceutical's strides in oncology. The use of lentinan injections underscores the company's role in advancing cancer treatment options.
These are crafted for the treatment of wound hemostasis, illustrating Jinling’s innovative approach to surgical and medical care supplies. The absorbable gelatin sponges highlight the company’s contribution towards improving surgical outcomes through effective hemostatic products.
In addition to these specialized products, Jinling Pharmaceutical Company Limited also offers a range of medical and health care services, further broadening its impact on the healthcare industry in China. These services emphasize the company's comprehensive approach to healthcare, providing end-to-end solutions from preventive measures to treatment and recovery support.